LUM/IVA + Placebo
ApprovedCompleted 0 watching 0 views this week🔥 Hot
84
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Cystic Fibrosis
Conditions
Cystic Fibrosis
Trial Timeline
Sep 1, 2016 → Oct 1, 2017
NCT ID
NCT02875366About LUM/IVA + Placebo
LUM/IVA + Placebo is a approved stage product being developed by Vertex Pharmaceuticals for Cystic Fibrosis. The current trial status is completed. This product is registered under clinical trial identifier NCT02875366. Target conditions include Cystic Fibrosis.
Hype Score Breakdown
Clinical
30
Activity
20
Company
9
Novelty
10
Community
12
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03061331 | Phase 2 | Completed |
| NCT02875366 | Approved | Completed |
Competing Products
20 competing products in Cystic Fibrosis